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Highly efficient optogenetic 
cell ablation in C. elegans using 
membrane-targeted miniSOG
Suhong Xu & Andrew D. Chisholm
The genetically encoded photosensitizer miniSOG (mini Singlet Oxygen Generator) can be used to 
kill cells in C. elegans. miniSOG generates the reactive oxygen species (ROS) singlet oxygen after 
illumination with blue light. Illumination of neurons expressing miniSOG targeted to the outer 
mitochondrial membrane (mito-miniSOG) causes neuronal death. To enhance miniSOG’s efficiency as 
an ablation tool in multiple cell types we tested alternative targeting signals. We find that membrane 
targeted miniSOG allows highly efficient cell killing. When combined with a point mutation that 
increases miniSOG’s ROS generation, membrane targeted miniSOG can ablate neurons in less than one 
tenth the time of mito-miniSOG. We extend the miniSOG ablation technique to non-neuronal tissues, 
revealing an essential role for the epidermis in locomotion. These improvements expand the utility and 
throughput of optogenetic cell ablation in C. elegans.
Cell ablation is a classic approach to understanding cell and tissue function in development or neural function in 
vivo. In Caenorhabditis elegans, laser ablation has been used to define the functions of many cell types1,2. However, 
identification of cells can be challenging and laser ablation experiments are labor intensive, especially for large 
cells, or complex sets of cells. Genetic cell ablation methods have therefore become increasingly widespread. In 
C. elegans, controlled expression of apoptotic factors has been used to ablate cells3,4. More recently, the geneti-
cally encoded photosensitizers KillerRed (KR) and miniSOG (mini singlet oxygen generator) have been used to 
ablate cells in C. elegans5–7. KR and miniSOG both generate reactive oxygen species (ROS) following exposure to 
high-intensity green or blue light respectively, allowing conditional cell ablation with a high degree of temporal 
control. Both photosensitizers have also been used for other applications, such as chromophore-assisted light 
inactivation (CALI)8–10 and photodynamic therapy11–14.
KR, derived from the hydrozoan GFP-like protein anm2CP, was the first genetically encoded photosensitizer 
shown to be effective for cell killing9. KR is a type I photosensitizer, generating the ROS superoxide after illumi-
nation with green light (585 nm excitation maximum). KR has been used to ablate cells in zebrafish15 and more 
recently in C. elegans6. Extensive analysis showed that KR could kill a variety of neuron types in C. elegans5. An 
advantage of KR is that green light is not toxic to C. elegans. However, some limitations of KR have been observed. 
For example, the superoxide generated by KR can be scavenged by endogenous pathways, possibly accounting for 
cell type dependent variation in KR killing efficiency5. Other researchers have reported toxicity of KR transgenes 
in the absence of green light irradiation16,17.
miniSOG, engineered from the LOV domain of Arabidopsis phototropin 2, was originally developed for cor-
relative light and electron microscopy18. After illumination with blue light (448 nm excitation maximum), mini-
SOG generates singlet oxygen (1O2) via a type II reaction18, and may also generate other ROS19. Expression of 
cytosolic miniSOG is not generally toxic to cells after blue light illumination. However, miniSOG targeted to the 
outer mitochondrial membrane results in cell degeneration and death after blue light illumination, presumably 
due to the generation of toxic levels of ROS at mitochondria7. Since its development as a cell killing tool, mini-
SOG has been used in a variety of ablation experiments20,21, using blue light exposures of 0.5–1.5 h. The need for 
extended blue light illumination potentially limits the use of miniSOG as C. elegans can be killed by long blue 
light exposure22. Blue light is perceived as noxious by C. elegans, in part because blue light generates ROS such as 
H2O223. High expression levels of mitochondrially targeted miniSOG may have deleterious effects in the absence 
of blue light irradiation, due to leaky ROS generation under ambient light7.
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Here, we demonstrate that membrane targeted miniSOG causes highly efficient ablation of multiple cell types, 
including neurons, muscles, and the epidermis. The cell killing effects of membrane-targeted miniSOG, like those 
of mito-miniSOG, are cell autonomous, and result in structural and functional deficits in targeted cells. We also 
find that a mutant version of miniSOG, previously shown to enhance singlet oxygen generation in vitro24 can 
further enhance cell killing efficiency in vivo. The combination of these changes yields a greater than ten-fold 
increase in miniSOG cell killing efficiency compared to mito-miniSOG, without overt deleterious effects in uni-
lluminated animals. We use this enhanced miniSOG to reveal a role for the epidermis in locomotor behavior.
Results
Expression of mitochondrial or membrane targeted miniSOG in the epidermis causes paralysis 
and death. Our initial goal was to test the effects of mitochondrial miniSOG in epithelial cells such as the epi-
dermis. We expressed miniSOG, fused to the N-terminal 55 amino acids of the outer mitochondrial membrane 
protein TOMM-20 (hereafter mito-miniSOG)7 (Fig. 1a), in the adult epidermis using the col-19 promoter. As 
controls, we used animals expressing cytosolic (non-targeted) miniSOG and mito-GFP (Tomm20 targeting). All 
such transgenic animals were indistinguishable from the wild type in behavior and morphology before illumina-
tion (Fig. 1b, Movie S1). After 12 min blue light illumination using an LED source with irradiance ~2 mW/mm2, 
cytosolic miniSOG or mito-GFP epidermal transgenic animals did not display altered behavior or morphology 
(Fig. 1b, Movie S1). In contrast, mito-miniSOG transgenic animals became paralyzed immediately after blue light 
illumination (Fig. 1b, Figure S1a, and Movie S2). These animals assumed a linear posture and could not move 
forwards or backwards, although local muscle twitches could be observed. Such animals eventually died within 
the next 4–6 hours.
To assess the overall health of epidermal mito-miniSOG transgenic animals, we measured their lifespan 
when cultured in the dark. We found that Pcol-19-mito-miniSOG expressing animals had a reduced lifespan 
whereas Pcol-19-miniSOG animals had a normal lifespan (Figure S1b), suggesting overexpression of epidermal 
mito-miniSOG may have subtly deleterious effects in the absence of illumination. In wild type animals, epidermal 
mitochondria form a complex tubular network25. Epidermal mitochondria appeared abnormal in morphology in 
mito-miniSOG expressing animals but were normal in animals expressing cytosolic miniSOG (Figure S1c). These 
observations suggested that mito-miniSOG overexpression can impair epidermal structure and function after 
blue light illumination, but also had slightly toxic effects in the epidermis in the absence of blue light.
We therefore explored whether other targeting signals could enhance miniSOG toxicity after blue light with-
out affecting organismal health in the absence of irradiation. As membrane targeting had been used in studies of 
KR mediated cell ablation5,9, we tested a membrane targeting signal widely used in C. elegans, the PH (Pleckstrin 
Homology) domain from rat PLC-δ 26 (Fig. 1a). PH domains bind phosphoinositides with high affinity, targeting 
proteins to the plasma membrane and may also target other organelle membranes (Figure S1d)27. As an alterna-
tive membrane targeting signal we tested the predicted myristoylation signal sequence from C. elegans NCS-2 
(Fig. 1a).
After 1 min continuous blue light illumination, 80% of Pcol-19-PH-miniSOG transgenic animals were para-
lyzed whereas 0% Pcol-19-mito-miniSOG transgenic animals were paralyzed (Figure S1a). As pulsed blue light is 
more effective than continuous blue light in mito-miniSOG based cell ablation7, we tested different frequencies 
and found 2 Hz (0.25 sec on and 0.25 sec off) to be most effective in paralyzing epidermal PH-miniSOG trans-
genic animals (Figure S1e). Unless stated, in subsequent experiments we use 2 Hz illumination.
After 12 min blue light exposure 50% of mito-miniSOG transgenic animals were paralyzed, whereas only 
2 min blue light was required to paralyze 50% of animals expressing PH-miniSOG at comparable levels (Fig. 1b,c, 
Movie S2, S3). This result suggested that PH-miniSOG might be more efficient than mito-miniSOG in disrupt-
ing epidermal function. Under blue light, 4 min illumination paralyzed 50% of Pcol-19-myr-miniSOG trans-
genic animals (Fig. 1b,c, Movie S4). 1 min illumination did not immediately paralyze either mito-miniSOG or 
PH-miniSOG transgenic animals (Fig. 1d), but significantly reduced the locomotion speed of PH-miniSOG 
transgenic animals (Fig. 1e, Figure S1f). 2 h after illumination, 100% of PH-miniSOG animals were paralyzed 
(Fig. 1d) and eventually died (defined as nonresponsive to touch) within the next 4–6 h (data not shown). In 
contrast, a small fraction of myr-miniSOG animals were paralyzed within minutes of 1 min illumination but 
fully recovered by 24 h later (Fig. 1d), whereas mito-miniSOG animals were superficially wild type immediately 
after illumination but paralyzed 8 h later and died by 24 h (Fig. 1d). These results suggest mito-miniSOG might 
have delayed or chronic effects upon blue light illumination, whereas PH-miniSOG has stronger acute effects. 
PH-miniSOG expressing animals were superficially wild type with normal lifespan, resembling cytosolic mini-
SOG expressing animals (Figure S1b, Movie S3). The fluorescence levels of membrane-targeted miniSOG were 
similar to or less than that of mito-miniSOG (Figure S1g,S1h), suggesting the improved killing efficiency of 
PH-miniSOG or myr-miniSOG does not reflect overall expression level.
The motor deficits and organismal death observed after expression of PH-miniSOG in the epidermis could 
reflect disruption of epidermal integrity. We examined epidermal morphology using Nomarski differential inter-
ference contrast (DIC) microscopy. The hyp7 and lateral epidermal seam cells were superficially wild type in 
morphology in PH-miniSOG expressing animals without blue light illumination (Fig. 1f). 4 h after 2 min blue 
light exposure, we observed dramatic changes in epidermal cell morphology, including cytosolic vacuolation 
and disruption of nuclear shape and position (Fig. 1f, Figure S2a). Cytosolic tdTomato fluorescence became dim-
mer and aggregated, and seam cells were thinner and degenerated (Fig. 1f). Illumination of animals expressing 
cytosolic miniSOG in the epidermis did not cause obvious defects in epidermal morphology (not shown). These 
results suggest PH-miniSOG generated ROS disrupts epidermal structure, leading to degeneration of the epider-
mis, and eventually organismal death.
As C. elegans epidermal cells do not normally undergo apoptosis28, we examined further the effects of 
PH-miniSOG. After blue light illumination, PH-miniSOG expressing animals displayed disrupted epidermal 
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Figure 1. Activation of miniSOG in the epidermis causes paralysis and disrupts epidermal integrity.  
(a) Cartoon of constructs targeting miniSOG to the outer membrane of mitochondria, and to cell membranes. 
(b) Representative images of adult animals immediately before and after blue light illumination. Blue light 
treatment results in paralysis of mito-miniSOG, myr-miniSOG, and PH-miniSOG expressing animals; times 
indicate the minimum time for immediate paralysis using 2 Hz blue light illumination. Scale, 250 μ m.  
(c) Quantitation of paralysis immediately after blue light illumination, for the indicated times. Numbers are the 
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microtubule architecture (Figure S2a). The normally tubular epidermal mitochondria became highly fragmented 
after illumination (Figure S2b). Damage to the epidermis, as caused by needle or laser wounding, can trigger 
expression of antimicrobial peptides (AMPs, such as nlp-29)29,30 (Figure S2c). PH-miniSOG expressing animals 
displayed reduced nlp-29-GFP signal 4 h after blue light illumination (Figure S2c), suggesting PH-miniSOG does 
not simply damage the epidermis but causes epidermal cell death.
Cell death could result from membrane damage due to excessive lipid peroxidation by high levels of ROS at 
the membrane, as in ferroptosis31. To test this hypothesis we examined lipid peroxidation levels in vivo using 
the fluorescent dye C11-Bodipy32. We found that lipid peroxidation dramatically increased after blue light illu-
mination of PH-miniSOG animals, but was unchanged from background levels in mito-miniSOG expressing 
animals (Fig. 1g,h). Together, these data suggest membrane-targeted miniSOG causes a widespread disruption 
of epidermal cell structure after blue light illumination, potentially due to increased lipid peroxidation leading to 
membrane damage. Further, the paralysis observed after epidermal disruption reveals a role for the epidermis in 
locomotion.
Membrane targeted miniSOG allows highly efficient neuronal ablation. To test whether 
membrane-targeted miniSOG is also more efficient than mito-miniSOG in other cell types, we expressed 
myr-miniSOG or PH-miniSOG in cholinergic motor neurons using the unc-17β promoter. Immediately after 
10 min blue light illumination, Punc-17β mito-miniSOG adult animals were severely uncoordinated (Unc) and 
coiled (Fig. 2b), consistent with earlier findings7. Both myr and PH membrane targeted miniSOG expressing 
animals displayed similar Unc phenotypes after blue light illumination, but using significantly shorter exposure 
times compared to mito-miniSOG (Fig. 2a,b, Movie S5). After 2 min blue light illumination, PH-miniSOG ani-
mals displayed significantly reduced locomotion velocity compared to mito-miniSOG animals (Fig. 2d). Normal 
locomotion was not restored in these animals after 96 h (data not shown), suggesting they had permanently lost 
neuronal function.
The irreversible behavioral deficits of Punc-17β -PH-miniSOG-expressing animals are consistent with cho-
linergic motor neuron degeneration and death, as previously characterized for mito-miniSOG7. To assess how 
PH-miniSOG affected neuronal morphology we used the Pacr-2-mCherry marker, expressed in an overlapping 
set of cholinergic motor neurons33. Most neurons displayed obvious degeneration, defined as thinning, vesicula-
tion, or loss of axons, and rounding-up of the cell soma (Fig. 2c, Figure S3a,c). Within 2–4 h of neuronal killing 
by PH-miniSOG we also observed abundant mCherry aggregates in the epidermis and in coelomocytes (Fig. 2c, 
Figure S3b,c), suggesting fragments of ablated cells are endocytosed by epidermis and coelomocytes. To assess 
the efficiency of Punc-17β-PH-miniSOG killing at the level of individual neurons we counted damaged cells and 
found over 90% of cell bodies were damaged 6 h after 3 min blue light illumination (Fig. 2e,f).
In summary, these data suggest PH-miniSOG is significantly more efficient than mito-miniSOG in neuronal 
ablations. MiniSOG has recently been found to generate ROS other than singlet oxygen in vitro19. This raises the 
possibility that cell killing efficiency could be limited by the activity of endogenous detoxification pathways such 
as superoxide dismutase, as was shown for KR5. We found that the efficiency of neuronal and epidermal killing 
by PH-miniSOG was not enhanced in animals lacking SOD-1, one of the two cytosolic superoxide dismutases34 
(Fig. 2e,f; Figure S4a,b). These observations suggest that superoxide detoxification may not be limiting for mini-
SOG killing, consistent with a role for singlet oxygen as the active species.
Membrane targeting of miniSOG improves killing efficiency in a variety of neurons. We next 
tested whether membrane targeting could improve miniSOG’s killing efficiency in other neuron types. We first 
examined GABAergic motor neurons. Animals expressing PH-miniSOG under the control of the unc-25/GAD 
promoter immediately displayed a shrinker Unc phenotype after 4 min blue light illumination (Fig. 3a, Movie S6) 
and displayed significantly reduced locomotion speed compared to animals expressing Punc-25-mito-miniSOG 
(Fig. 3b). Punc-25-PH-miniSOG animals displayed a more penetrant shrinker phenotype upon nose touch 
(Fig. 3c), consistent with the higher efficiency of PH-miniSOG over mito-miniSOG.
We then examined mechanosensory neurons, for which mito-miniSOG had not previously been tested. 
Animals expressing mito-miniSOG or PH-miniSOG in the six touch neurons (mec-4 promoter) displayed nor-
mal touch neuron morphology and mechanosensory behavior prior to blue light illumination (Fig. 3d,e). After 
4 min blue light illumination Pmec-4-PH-miniSOG expressing animals displayed more penetrant touch response 
animals that were analyzed in three independent experiments. (d). Quantitation of paralysis at different time 
points after 1 min blue light illumination. Paralyzed and non-paralyzed animals were counted at specific times 
after illumination. 4 independent experiments. Numbers are the animals that were analyzed. (e) Quantitation 
of locomotion velocity before and immediately after 1 min blue light illumination at 2 Hz. Transgenic animals 
were illuminated on 3 cm unseeded plates first and transferred to unseeded plates immediately afterwards for 
automated worm tracking. Numbers are the animals that were analyzed. (f) Representative DIC and confocal 
images of epidermis before and 4 h after 2 Hz blue light illumination. Images are from live, paralyzed animals 
expressing Pcol-19-PH-miniSOG. Left, DIC images, N indicates nuclei; arrows indicate vacuoles. Right, 
epidermal cells were labeled by Pcol-19-tdTomato. Yellow arrow indicates degenerated seam cell and white 
arrows indicate hyp7 after blue light illumination. Aggregation and decrease of the tdTomato fluorescence signal 
is evident. Red dash lines indicate epidermal edges. Scale, 10 μ m. (g) Blue light illumination of PH-miniSOG 
in the epidermis increases lipid peroxidation. Representative confocal images of Bodipy C11 staining in lateral 
epidermis. Scale, 10 μ m. (h) Quantitation of relative Bodipy C11 fluorescence intensity (AU). ***P < 0.001, 
Student’s t-test. Numbers are the animals that were analyzed.
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Figure 2. Membrane targeting enhances the efficiency of miniSOG mediated cholinergic neuron ablation. 
(a) Photoablation of cholinergic motor neurons by PH-miniSOG results in uncoordinated movement 
immediately after 4 min blue light illumination. Scale, 250 μ m. (b) Quantitation of Unc animals immediately 
after blue light illumination, for the indicated times. Membrane targeted miniSOG transgenic animals required 
shorter illumination times to display comparable Unc phenotypes. Numbers are the animals that were analyzed 
in three independent experiments. (c) Morphology of cholinergic motor neurons 4 h and 24 h after 4 min blue 
light illumination of PH-miniSOG. Motor commissures have disappeared and the remaining dorsal and ventral 
cord processes have degenerated into puncta. The unc-17β and acr-2 promoters are both expressed in the DA, 
DB, VA and VB neurons. White arrows indicate ventral and dorsal nerve cords. White arrowheads indicate 
motor neurons, red arrowheads indicate accumulation of mCherry in the epidermis, and yellow arrow indicates 
accumulation of mCherry in coelomocytes. Scale, 20 μ m. (d) Quantitation of locomotion velocity immediately 
after blue light illumination (2 min, 2 Hz). PH-miniSOG transgenic animal displayed significantly reduced speed 
compared to mito-miniSOG. Worm locomotion was analyzed by multi worm tracker; in this and subsequent 
panels n in bars denotes numbers of animals analyzed in three independent experiments. mean ±  SEM. 
***P < 0.001, t-test. (e) Representative morphology of cholinergic motor neurons before and 6 h after 3 min 
continuous blue light illumination in WT and sod-1(tm776) mutant animals expressing Punc-17β-PH-miniSOG. 
Blue light illumination was performed on L3 larvae, and animals imaged 6 h later (early L4 stage). White arrows 
indicate damaged cell bodies in the ventral nerve cord. The damaged cells eventually died. Yellow arrow indicates 
accumulation of mCherry in coelomocytes. Scale, 10 μ m. (f) Quantitation of damaged VNC cholinergic motor 
neurons 6 h after 1 min and 3 min continuous blue light illumination (see representative images in Panel c) in 
WT and sod-1(tm776) mutant animals. n, number of cells. ns, not significant, Student’s t-test.
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defects compared to animals expressing Pmec-4-mito-miniSOG (Fig. 3e). 24 h later the axons of all touch neurons 
(ALM, PLM, AVM, and PVM) became punctate and the somas were swollen (Fig. 3d, Figure S5b), consistent with 
axonal degeneration and cell death.
Finally, we tested the ability of PH-miniSOG to kill interneurons, loss of function in which results in backward 
movement defects. Expression of PH-miniSOG or mito-miniSOG expression under the control of the nmr-1 
promoter caused interneuron degeneration by 24 h post illumination. Pnmr-1-PH-miniSOG expressing animals 
displayed significantly more penetrant backward movement defects immediately after illumination compared to 
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Figure 3. Membrane targeting enhances the efficiency of miniSOG mediated GABAergic, touch, and 
interneuron ablation. (a) Punc-25-PH-miniSOG transgenic animals display Unc phenotypes immediately  
after 4 min blue light illumination, whereas Punc-25-mito-miniSOG animals did not. Scale, 250 μ m.  
(b) Quantitation of locomotion speed immediately after blue light illumination. Punc-25-PH-miniSOG 
transgenic animals displayed significantly reduced speed compared to Punc-25-mito-miniSOG. Numbers are 
the animals analyzed in 2 independent experiments. ***P < 0.001, t-test. (c) Quantitation of shrinker  
phenotype in Punc-25-mito-miniSOG and Punc-25-PH-miniSOG expressing animals, before and after blue 
light illumination (4 min at 2 Hz). n > 30 animals for each transgenic animal. ***P < 0.001, t-test.  
(d) Representative confocal images of PLM neurons before and 24 h after 4 min blue light illumination. The 
PLM neuron is degenerated in mito-miniSOG and in PH-miniSOG transgenic animals after illumination. 
Arrows indicate PLM processes. Scale, 20 μ m. (e) Quantitation of touch responses in Pmec-4-mito-miniSOG 
and Pmec-4-PH-miniSOG before and after blue light illumination. ***P < 0.001, t-test. (f) Quantitation of 
backward movement after head touch in Pnmr-1-mito-miniSOG and Pnmr-1-PH-miniSOG transgenic animals 
after blue light illumination. ***P < 0.001, t-test. (g) Representative confocal images of PVC neurons before 
and 24 h after 4 min blue light illumination. PVC neuron is degenerated in mito-miniSOG and PH-miniSOG 
transgenic animals after illumination. White arrow indicates PVC neurons and yellow arrows indicate mCherry 
debris in the epidermis. Scale, 10 μ m.
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animals expressing Pnmr-1-mito-miniSOG (Fig. 3f,g). Overall, our data show that PH-miniSOG is more efficient 
than mito-miniSOG for killing a variety of neuron types.
Membrane targeted miniSOG allows efficient ablation of muscle cells. We then tested whether 
membrane-targeted miniSOG is also more efficient than mito-miniSOG in muscle cells. Animals expressing 
PH-miniSOG driven by the myo-3 promoter were superficially wild type, and after 3 min blue light illumination 
were completely paralyzed; such paralyzed animals were distinguishable from epidermal miniSOG animals in 
that they displayed a kinked posture but did not undergo local muscle twitching (Fig. 4a,b, Movie S7). Pmyo-
3-mito-miniSOG animals did not show any locomotor defects under similar illumination conditions (Fig. 4b). 
The locomotion of Pmyo-3-PH-miniSOG expressing animals was also significantly reduced immediately after 
2 min illumination (Fig. 4c). Muscle cells in these animals appeared severely damaged as early as 4 h after illumi-
nation (Fig. 4d); muscle structure or function were not recovered by 24 h (Fig. 4d). These data show membrane 
targeted miniSOG is able to kill muscle cells more efficiently than mito-miniSOG.
Ablation by membrane-targeted miniSOG is cell autonomous. Cell ablation by mito-miniSOG has 
been shown to be cell-autonomous7. To test whether membrane-targeted miniSOG ablation is also cell auton-
omous we examined neurons and muscles located close to PH-miniSOG expressing cells. First, we examined 
GABAergic motor neurons in animals expressing PH-miniSOG in cholinergic motor neurons. Cholinergic neu-
rons were largely disrupted after blue light illumination (Fig. 5a,b), but nearby GABAergic neurons remained 
intact (Fig. 5a,b). Activation of miniSOG in the cholinergic motor neurons immediately caused Unc phenotypes, 
which might also result from damage to muscle cells. We found muscle cells were overall morphologically nor-
mal in animals expressing PH-miniSOG in the cholinergic motor neurons (Fig. 5c). PH-miniSOG activation 
in GABA motor neuron caused their degeneration, but did not appear to alter morphology of adjacent neurons 
(Figure S5a). Together, these results suggest that membrane targeted miniSOG cell killing is cell-autonomous and 
does not spread to adjacent tissues.
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The Q103L variant increases miniSOG’s cell killing efficiency. Recently, a mutant version of mini-
SOG in which a glutamine is replaced by a leucine has been found to result in a higher quantum efficiency of 
singlet oxygen production in vitro24. We tested this mutant (Q103L in our residue numbering) in our cell ablation 
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assays. Animals expressing PH-miniSOG(Q103L) in the epidermis were superficially wild type in the absence of 
blue light illumination (Figure S6a). After 2 min illumination, the WT and Q103L animals displayed similar rates 
(~90%) of acute paralysis (Fig. 6a). However, after 1.5 min blue light, the Q103L variant caused a slight increase 
in acute paralysis; ~70% of PH-miniSOG(Q103L) animals were paralyzed, compared to 20% of PH-miniSOG 
(WT) animals (Fig. 6a), suggesting that the Q103L variant may be slightly more effective than WT miniSOG. We 
then examined the longer-term effects of brief blue light exposures. Notably, after 1 min blue light illumination, 
the PH-miniSOG(Q103L) animals became completely paralyzed within 15 min, whereas PH-miniSOG(WT) 
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were not fully paralyzed until 2 h post illumination (Fig. 6b). PH-miniSOG(Q103L)-expressing animals were 
also slightly more sensitive to continuous light (Fig. 6c). We exposed both types of transgenic animals to 20 sec 
continuous blue light, which did not result in acute paralysis. However PH-miniSOG(Q103L) animals became 
completely paralyzed within 2 h of illumination and did not recover (Fig. 6d), whereas PH-miniSOG animals 
were slightly slow-moving (Fig. 6d), and were superficially wild type 24 h later (data not shown). Animals express-
ing the Q103L variant were also more sensitive to illumination with 30 sec pulsed light (Figure S6b). These results 
suggest the Q103L mutation enhances the efficacy of miniSOG in epidermal cell killing.
A possible explanation for the stronger cell killing of the Q103L variant is that its expression or stability could 
be higher than miniSOG(WT). Yet, miniSOG(Q103L) transgenic animals showed significantly lower fluores-
cence intensity than miniSOG(WT) (Fig. 6e,f). The increase in efficacy of the Q103L variant is thus unlikely to be 
due to differences in expression, but rather by the increased production of singlet oxygen24.
We then tested whether miniSOG(Q103L) enhanced cell killing ability in cholinergic motor neurons. 
Punc-17β-PH-miniSOG(Q103L) transgenic animals displayed normal locomotion (Figure S6c). After 2 min 
pulsed light approximately 90% of Punc-17β-PH-miniSOG(Q103L) animals displayed uncoordinated move-
ment, whereas a comparable phenotype takes 4 min for PH-miniSOG(WT) (Fig. 6g). 30 sec of continuous 
blue light illumination had no acute effect on Punc-17β-miniSOG(WT) animals but caused ~30% of Punc-
17β-miniSOG(Q103L) animals to be Unc (Fig. 6h). Similarly, 1 min illumination resulted in 90% of Punc-
17β-miniSOG(Q103L) animals being immediately Unc, compared to less than 20% of Punc-17β-miniSOG(WT) 
transgenic animals (Fig. 6h). 20 sec continuous blue light did not result in acute Unc phenotypes in either trans-
genic strain, but within 2 h of exposure 60% Punc-17β-PH-miniSOG(Q103L) animals became completely Unc, 
and did not recover normal locomotion (Figure S6d), whereas only 10% Punc-17β-PH-miniSOG(WT) animals 
were Unc within 2 h (Figure S6d). These results suggest the Q103L mutant miniSOG enhances the acute and 
delayed toxic effects of miniSOG expression.
Discussion
The original mitochondrially targeted miniSOG allowed effective optogenetic cell ablation in C. elegans, but often 
required long illumination times to achieve full cell killing7. Moreover, epidermal mito-miniSOG expression 
alters mitochondrial morphology (this study), an effect that might be less readily detected in neurons. This effect 
may in part reflect overload of the mitochondrial import apparatus and in part the effects of low levels of ROS 
generated in the absence of blue light. The aberrant mitochondrial morphology and decreased lifespan of epider-
mal mito-miniSOG-expressing animals prompted this investigation into alternative ways to target miniSOG. We 
find that the combination of membrane targeting and the Q103L point mutation allows highly efficient miniSOG 
mediated ablation, requiring much shorter illumination times. Importantly, the faster cell killing remains cell 
autonomous, permanent, and in the absence of blue light illumination the killing transgenes appear to have no 
toxic effects. As blue light is toxic to C. elegans, these improvements should significantly enhance the utility of 
miniSOG as an optogenetic tool.
Membrane targeting by the PH domain was more efficient in cell disruption than mito-miniSOG for all cell 
types tested (epidermis, neurons, and muscle). In the epidermis and cholinergic neurons, membrane targeting by 
myristoylation was also more effective than mito-miniSOG, but not quite as effective as PH-miniSOG. We note 
that in our analysis of cholinergic, GABAergic, and interneuron killing we used mito-miniSOG transgenes gen-
erated at DNA concentrations 2.5-fold higher than the PH-miniSOG transgenes made here. These comparisons 
may thus slightly underestimate the relative efficiency of PH-miniSOG. Our comparisons of epidermal, muscle, 
and touch neuron disruption used transgenes that were generated at similar DNA concentrations and suggest that 
PH-miniSOG is approximately 5–6 times as potent as mito-miniSOG.
The PH domain used here confers plasma membrane targeting in C. elegans embryos26, but in the differenti-
ated epidermis also localizes to membrane associated puncta (Fig S1d), possibly corresponding to stacks of invag-
inated apical plasma membrane frequently seen in EM sections of the epidermis. Myristoylation sequences also 
target primarily to the plasma membrane35, but were less effective in our assays, suggesting plasma membrane 
targeting may not fully account for the enhanced effects of PH-miniSOG. Other membrane targeting signals have 
been used for KR in zebrafish15, and could be tested in future work, although in C. elegans cell killing by myristoy-
lated KR had efficacy similar to that of cytosolic KR5.
A significant enhancement in miniSOG killing efficiency resulted from the missense mutation Q103L. This 
mutation was engineered to reduce hydrogen bonding between the miniSOG protein and its flavin mononu-
cleotide (FMN) chromophore, reducing the competing electron transfer reaction to FMN and allowing greater 
electron transfer to generate singlet oxygen24. In vitro, the Q103L variant displays about a 5-fold increase in quan-
tum efficiency of singlet oxygen production. Although we have not yet been able to measure singlet oxygen in 
C. elegans in vivo, our observations in the context of membrane targeted miniSOG show that the Q103L change 
causes a small, but significant, increase in cell killing efficiency, more pronounced when the delayed effects of 
miniSOG are examined. Additional evolution of miniSOG for improved quantum yield may further enhance cell 
killing efficacy.
ROS generation by miniSOG triggers a sequence of cellular changes that result in cell degeneration and death. 
These changes may differ depending on the cell type and the subcellular targeting of miniSOG. Previous analysis 
indicated that mito-miniSOG induced neuronal death was independent of the apoptotic or phagocytic pathways7. 
The effects of membrane targeted miniSOG resemble those of mito-miniSOG, but might be triggered in different 
ways. Membrane damage by photosensitizers is thought to cause loss of cell integrity and necrosis, due to the 
oxidation of lipid bilayers36. Membrane miniSOG induced death may be the result of a similar non-physiological 
cell disruption. Elevated membrane lipid peroxidation has been observed in a non-apoptotic cell death pathway 
known as ferroptosis31. Although ferroptosis has not been reported in C. elegans, membrane-targeted miniSOG 
could cause cell death by a related mechanism. The absence of functional recovery after ablations is consistent 
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with irreversible cell damage, and argues against functional compensation from other cells or from regenerative 
pathways.
Membrane-targeted miniSOG transgenic animals appear superficially normal under standard culture con-
ditions (ambient light, room temperature), suggesting membrane targeted miniSOG is not strongly toxic in the 
absence of blue light. As a precaution in this work, we reared animals in the dark, but this does not appear 
to be necessary for routine experiments. Although the enhanced miniSOG killing minimizes use of blue light, 
it should be kept in mind that blue light exposure has complex effects on C. elegans behavior22,23,37. Analysis 
of miniSOG-ablated animals should always be precisely controlled for the effects of blue light exposure. The 
use of PH-miniSOG raises a further concern of whether ROS generated close to the cell surface might have 
cell-non-autonomous effects. However, our analysis suggests PH-miniSOG mediated cell ablation does not 
damage adjacent cells. While the cell degeneration and killing effects of PH-miniSOG appear to be cell autono-
mous, we note that after neuronal or muscle killing, cellular debris accumulated in epidermis and coelomocytes, 
consistent with the idea that the epidermis is responsible for clearance of cell fragments28,38. Activation of such 
non-autonomous clearance pathways is therefore an expected consequence of the widespread cell fragmentation 
induced by optogenetic cell killing.
We find that optogenetic disruption of the epidermis causes acute paralysis. These findings echo an early 
observation that ectopic expression of the MEC-4 DegENaC channel in the epidermis caused abnormal move-
ment39 and suggest a role for the epidermis in locomotion. The epidermis has numerous physiological functions 
in the adult28. Importantly, the paralysis observed after epidermal disruption was distinguishable from that caused 
by ablation of body wall muscles (compare Movie S3 and S7), suggesting epidermally disrupted animals are not 
paralyzed simply due to a secondary disruption of muscle function. The epidermis physically links the muscula-
ture and the exoskeleton (cuticle), and epidermal ion transport regulates the function of the motor circuit40. As 
epidermally disrupted animals display local, uncoordinated muscle contractions, one model is that in such ani-
mals muscles are able to contract but are unable to transduce force through the epidermis. However, disruption 
of the epidermis may cause additional functional deficits in the locomotor circuit. The increased efficiency in cell 
killing allowed by membrane targeted miniSOG should facilitate its use in C. elegans and may also be relevant to 
applications in photodynamic therapy.
Materials and Methods
C. elegans genetics and transgenes. C. elegans strains were maintained on nematode growth medium 
(NGM) plates seeded with E. coli OP50 at 22 °C except when otherwise noted. All miniSOG transgenic animals 
described here appear superficially wild type in behavior and morphology in the absence of blue light illumi-
nation. In general, miniSOG transgenic strains can be propagated in normal ambient light (on the lab bench or 
incubator). For all experiments (unless otherwise stated) in this paper, we grew dark-reared animals by picking 
parental animals in the L4 stage and keeping them in foil-covered boxes until the experimental manipulation.
Plasmids and strains used in this study are listed in Table S1. Comparisons of miniSOG variants in the epi-
dermis used transgenic arrays made by injection of similar concentrations of test DNA. Neuronally expressed 
mito-miniSOG arrays were generated at 50 ng/μ l, compared to 20 ng/μ l for membrane miniSOG. At least 2 trans-
genes were tested per experiment; representative arrays are listed in Table S1.
Blue light illumination. We used a blue LED (UHP-MIC-LED-460) light source (460 ± 5 nm, spectrum half 
width 27 nm, Prizmatix, Givat Shmuel, Israel) for illumination as described10. Briefly, the irradiance at the spec-
imen was 2.01 mW/mm2 as measured using a D10MM power sensor connected to a PM50 Optical Power Meter 
(Thorlabs, Newton, New Jersey, US). Pulse frequency was controlled by a digital function generator/amplifier 
(PI-9587C, PASCO, Roseville, CA). The light source was ~10 cm above the plate surface. To illuminate animals, 
we transferred 15–20 young adults to a 3 cm unseeded NGM plate poured with 60 μ l of 100 mM CuCl2 on the rim 
of the plate. The blue light illumination covers the entire plate surface. Overall, the irradiance of our LED setup 
is approximately 3.5× higher than that of the epifluorescence setup tested previously and has a slightly different 
excitation spectrum7. After illumination, animals were kept in the dark until analysis.
Behavior analysis and quantitation. Animals were defined as paralyzed if they were unable to move 
forward or backward, whether or not they displayed any local or ineffective muscle contractions. We used a 
multi-wormtracker to measure locomotion speed41. Touch response assays were performed as previously 
described42. Each animal was tested by touching the head five times and by touching the tail five times, and the 
data combined for statistical analysis. The shrinker Unc phenotype (for Punc-25-PH-miniSOG) and backward 
movement Unc phenotype (Pnmr-1-PH-miniSOG) were measured after head touch with worm pick. To quanti-
tate miniSOG induced paralysis or other locomotor phenotypes, at least three independent experiments (10–15 
animals each) were performed.
Bodipy C11 staining. Epidermal mito-miniSOG and PH-miniSOG transgenic animals were illuminated 
with blue light for 2 min then after 1.5 h were transferred into 10 μ M Bodipy 581/591 C11 solution and stained for 
30 min. Non-illuminated transgenic animals served as controls. Animals were washed with M9 for three times 
and imaged with Zeiss 710 confocal microscope using a 561 nm excitation laser and LP 590 nm emission filters. 
Relative fluorescence intensity was quantified using MetaMorph.
Imaging. For fluorescence imaging of epidermal and neuronal cells, young adult worms were anesthetized 
with 12 mM levamisole on 2% agar pads. Z-stack images were captured either on a Zeiss LSM710 confocal 
microscope with 63× , NA 1.4 objective or on an ANDOR spinning disk confocal microscope with 63× , NA 1.4 
objective with an ANDOR iXon Ultra camera. Maximum intensity projections and adjustment of brightness and 
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contrast were performed using Metamorph software. Whole animal fluorescence images were taken using a Zeiss 
Diskovery V12 dissecting stereomicroscope with Nikon DS Qi-1 monochrome camera. Nomarski DIC images 
were taken on a Zeiss Axioplan 2 microscope using a 100× , NA 1.4 oil objective.
Statistics. All statistical tests used GraphPad Prism. Two-way comparisons used Student’s t test. Survival 
proportions used curve comparison. For multiple comparisons, we used one-way ANOVA.
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